BIOMARIN PHARMACEUTICAL INC - FORM 10-K - EX-23.1 - CONSENT OF KPMG LLP - February 26, 2010

Attached files

file filename
10-K - FORM 10-K - BIOMARIN PHARMACEUTICAL INCd10k.htm
EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 - BIOMARIN PHARMACEUTICAL INCdex311.htm
EX-32.1 - CERTIFICATION OF CEO AND CFO PURSUANT TO SECTION 906 - BIOMARIN PHARMACEUTICAL INCdex321.htm
EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 - BIOMARIN PHARMACEUTICAL INCdex312.htm
EX-23.2 - CONSENT OF PRICEWATERHOUSECOOPERS, LLP - BIOMARIN PHARMACEUTICAL INCdex232.htm
EX-10.37 - STOCK PURCHASE AGREEMENT - BIOMARIN PHARMACEUTICAL INCdex1037.htm
EX-21.1 - SUBSIDIARIES OF BIOMARIN PHARMACEUTICAL INC. - BIOMARIN PHARMACEUTICAL INCdex211.htm
EX-99.1 - BIOMARIN/GENZYME LLC CONSOLIDATED FINANCIAL STATEMENTS - BIOMARIN PHARMACEUTICAL INCdex991.htm

Exhibit 23.1

 

Consent of Independent Registered Public Accounting Firm

 

The Board of Directors and Stockholders

BioMarin Pharmaceutical Inc.:

 

We consent to the incorporation by reference in the registration statements (Nos. 333-136963, 333-84787, and 333-85368) on Form S-8 of BioMarin Pharmaceutical Inc. and subsidiaries of our reports dated February 25, 2010, with respect to the consolidated balance sheets of BioMarin Pharmaceutical Inc. and subsidiaries as of December 31, 2009 and 2008, and the related consolidated statements of operations, changes in stockholders’ equity (deficit) and comprehensive income (loss), and cash flows for each of the years in the three-year period ended December 31, 2009, and the effectiveness of internal control over financial reporting as of December 31, 2009, which reports appear in the December 31, 2009 annual report on Form 10-K of BioMarin Pharmaceutical Inc.

 

Our reports were based on our audits and the report of other auditors.

 

/s/ KPMG LLP

 

San Francisco, California

February 25, 2010

Stock widget

Investing forum

BIOMARIN PHARMACEUTICAL INC Reports